GCG and metabolic dysfunction-associated steatohepatitis: The combined use of these agents with a GLP-1 agonist might have a dramatic effect on improving the hepatocyte inflammatory response in NASH, as does the addition of Ezetimibe (Zetia) to HMGR inhibitors [146,147].